Kavish Patidar
@KavishPatidar11
transplant hepatologist; focus on hepatorenal syndrome & AKI in cirrhosis, critically ill patients with cirrhosis, and ETOH hepatitis. Thoughts are my own.
Amazing multidisciplinary collaboration with rigorous adjudication at each site. Key points: *HRS is uncommon in the US (12.1%) *ATN is important and we need to start shifting our focus to this important etiology
Newly published @HrsHarmony study: Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US - Journal of Hepatology journal-of-hepatology.eu/article/S0168-…
A much needed consensus. Led by @docsudhakodali1. @MethodistHosp
🔥Hot Topic in @LTxJournal! An international consensus conference was convened by the @_ILTS_ and the @ILCAnews to establish a more universal consensus regarding #livertransplantation for oncologic indications. 👀 Read the Consensus statement: bit.ly/4kVBYmV
📣New data on cirrhosis recompensation in @JHepatology ✅Only 7% meets strict Baveno VII criteria ✅Expanded criteria capture ~38% with similar low mortality risk Recompensation: ⬇️systemic inflammation🔥 👍 improved hemodynamic ⬆️improved survival doi.org/10.1016/j.jhep…
The jefe! My go to for anything related to methods and analysis plan. 🔥Liver risk score predicts liver related events with excellent performance in a diverse US veteran population.
💬 on a✈️ to 📝 with @AnandVKulkarni2 🔸So we all 🗣️AKI in CLD 🔸But ⁉️ESRD with ascites on consults (and they aren't uncommon) 🔸We dig deep -SAAG 🚫 -Causes: Mixed bag -Nephrogenic ascites 📈 ☠️ - 💊❓ Large gaps in 📝 @ebtapper @LiverFellow @AASLDtweets journals.lww.com/hepcomm/fullte…
Original Article Acute encephalopathy without hyperammonemia has a different presentation than overt HE and displays a similarly severe prognosis Desplats et al. #LiverX tinyurl.com/265wwdeh
Artículo Original Corticosteroides en la hepatitis asociada a alcohol severa: No tan rápido: Una revisión sistemática de ensayos controlados aleatorizados. Shi, Pungwe et al. #LiverX tinyurl.com/mzzk8uar
📣@ICA_Global_AKI published in @LancetGastroHep 🗺️3,821 patients with cirrhosis ✅38% had AKI ⚠️discrepancies in AKI management and outcomes ⚠️ AKI ➡️22.9% 28-day mortality 🎯Need for equitable & standardized care thelancet.com/journals/langa…
Check out our latest article. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: A randomized, single-blind clinical trial - JHEP Reports jhep-reports.eu/article/S2589-… @JHEP_Reports @EASLnews @BavenoCoop @liverunitclinic
TCorticosteroids in severe alcohol-associated hepatitis? Not so fast! @avegailf @HEP_Journal @rabataller @KanwalFasiha @juanpabloarab @GCholankeril @KavishPatidar11 @KanwalFasiha @HowardTLeeMD @Dr_Vijay_Shah @magicbaby6 @AsraniSumeet tinyurl.com/2kzac7r8
⏰ Early treatment of HRS-AKI is key, but how early is too early? Facts: 1️⃣volume responsive AKI is 3x more common than HRS-AKI 2️⃣HRS-AKI patients have effective hypovolemia by definition ➡️volume challenge is essential 3️⃣central volume overload? Terlipressin is not an option
Kickstarting the inaugural GLOBAL LIVER SAFETY EXPERTS @cancun with THE expert @nagachalasani @avantsantemx @rajVuppaLanchi @orman_md @lilydaramd @craiglammertIU
@KavishPatidar11 breaking ground research presented @AASLDtweets @HealioGastro @bcm_gihep -way to go! healio.com/news/hepatolog…
Hear from @KavishPatidar11 of @bcmhouston as he discusses the impact of country-level socioeconomic status and healthcare delivery on acute #kidney injury outcomes in patients with #cirrhosis. hcplive.com/view/country-l…